Investment Thesis
Carduso Capital invests in technology-driven companies rooted in the Groningen region, leveraging academic research (UG/UMCG) to address clear market needs. Focus on long-term partnerships, active management support, and scalable returns.
Stage Focus
Early-stage spin-offs, startups, and established companies (proof of concept + prototype preferred; investments range from €100K to €5M).
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Innovative technology companies with strong ties to University of Groningen (UG) and University Medical Centre Groningen (UMCG); early-stage spin-offs, startups, and established companies expanding on research and technology.
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€100,000 - €5,000,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
Investment Team (10)
B
Bart Jan Korteling
Expert panel - Medical device expert
F
Frits Kok
Partner
H
Hans Biemans
Committee of Recommendation - vz President RUG
H
Harm Wesseling MBA
Expert panel - Directeur ICT & Medische Techniek Martini Ziekenhuis & Voorzitter ICT Board Santeon
H
Henk Snapper
Committee of Recommendation - Member Board of Directors UMCG
J
Jouke de Vries
Committee of Recommendation - President RUG
K
Koos Koops
Partner
P
Prof. Dr. Lubbert Dijkhuizen
Expert panel - Hoogleraar Microbiologie & Initiatiefnemer en medeoprichter van het “Carbohydrate Competence Centre" (CCC)
R
Robert Polano
Partner
T
Ton Rijnders
Expert panel - Scientific Director of Top Institute Pharma
